An enlightening study by Lin et al. provided evidence that transgenic mice overexpressing miR-155 have hypoglycemia, improved glucose tolerance, and insulin sensitivity, whereas miR-155 deficiency caused the opposite effects [39]. The gene discussed is INS; the disease is Hypoglycemia.